Showing all 4 resultsSorted by latest
Afanix (Afatinib 40 mg) by Beacon Pharmaceutical is an EGFR tyrosine kinase inhibitor used for treating EGFR-positive metastatic non–small cell lung cancer and squamous NSCLC after chemotherapy.
It helps slow disease progression by blocking cancer-driving EGFR and HER2 pathways.
Pack: 3 × 10 tablets
Afanix Price: PKR 44,487
Hernix 40 mg (Neratinib) by Beacon Pharmaceuticals Ltd. is a targeted oral anticancer therapy used for HER2-positive early and metastatic breast cancer. It irreversibly inhibits HER2 and EGFR receptors to prevent cancer recurrence and progression.
Each pack contains 180 tablets, priced at PKR 446,250.
Use only under medical supervision. The product image may differ from the actual packaging.
Olaparix 150 mg (Olaparib) by Beacon Pharmaceuticals Ltd. is a targeted anticancer therapy belonging to the PARP inhibitor class.
It is indicated for BRCA-mutated ovarian, breast, pancreatic, and prostate cancers, helping prevent cancer cell repair and promoting their destruction.
Each pack contains 120 tablets, priced at PKR 255,000.
Use only under oncologist’s supervision.
The product image may vary from the actual item.
Product Name: Afatinib (Afanix 40 mg Tablets)
Brand: Afanix
Strength: 40 mg Tablet
Manufacturer: Beacon Pharmaceutical
Pack Size: 30 Tablets (3 x 10’s blister packs)
Price: PKR 44,487 per pack
Afanix (Afatinib 40 mg) by Beacon Pharmaceutical is an oral targeted therapy used for the treatment of EGFR mutation–positive non-small cell lung cancer (NSCLC).
Afanix works by irreversibly blocking EGFR and other ErbB receptors to slow cancer progression and improve treatment outcomes.
Taken once daily, it offers a convenient and effective option for patients requiring EGFR-targeted therapy.
Use only under the supervision of an oncologist.